Biotech Values

[DewDiligence]

FCSC—I’ve already presented an argument for why laViv won’t garner commercial sales of any consequence. If you’re now looking for a reason why the FDA might not approve the product, you can start with the fact that there is no medical need for another dermal filler to treat nasolabial folds.